Notch1 and ERK activation were associated with poor DFS and OS, and combinatorial targeting of the two pathways significantly reduced proliferation and survival in breast cancer cell lines, inhibited sphere formation, and yielded tumor regression in xenograft models [156]. The gene discussed is MAPK1; the disease is breast cancer.